Crohn's Disease

The Crohn's Disease pipeline: 68 tracked drugs, 36 approved for this indication.

36 approved / phase 47 Phase 31 Phase 2/310 Phase 23 Phase 1/210 Phase 11 preclinical / unstaged

Compare the share prices of listed companies in Crohn's Disease →

Total attributable cost

$17.7B

$17,463/patient

Drug spend

Not yet sourced

How this is calculated ↗

All severities · US

The Crohn's Disease pipeline

Key trial results for every approved and late-stage drug: Crohn's Disease results by drug.

← all assets